Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Ethyl 3 methylimidazolium Acetate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110294712B reveals a novel two-step synthesis for high-purity imidazole acetate ionic liquids, offering >99% purity and minimal halide residues for industrial applications.